| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 2.84e-07 | 5 | 62 | 3 | GO:0005007 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 4.95e-05 | 65 | 62 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | fibroblast growth factor binding | 7.91e-05 | 27 | 62 | 3 | GO:0017134 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.41e-04 | 85 | 62 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | translation initiation factor binding | 2.41e-04 | 39 | 62 | 3 | GO:0031369 | |
| GeneOntologyMolecularFunction | heparin binding | 3.24e-04 | 192 | 62 | 5 | GO:0008201 | |
| GeneOntologyMolecularFunction | eukaryotic initiation factor 4E binding | 5.12e-04 | 11 | 62 | 2 | GO:0008190 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.07e-03 | 145 | 62 | 4 | GO:0004713 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.45e-03 | 268 | 62 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | collagen binding | 2.05e-03 | 81 | 62 | 3 | GO:0005518 | |
| GeneOntologyBiologicalProcess | respiratory tube development | 1.56e-05 | 273 | 61 | 7 | GO:0030323 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 2.40e-05 | 404 | 61 | 8 | GO:1903532 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor apoptotic signaling pathway | 2.58e-05 | 3 | 61 | 2 | GO:1902178 | |
| GeneOntologyBiologicalProcess | cochlea development | 3.18e-05 | 61 | 61 | 4 | GO:0090102 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion | 4.06e-05 | 435 | 61 | 8 | GO:0051047 | |
| GeneOntologyBiologicalProcess | alveolar secondary septum development | 5.14e-05 | 4 | 61 | 2 | GO:0061144 | |
| GeneOntologyBiologicalProcess | growth | CACNA1C DDR1 TENM4 ATN1 FN1 EIF4G1 DVL1 DACT3 FGFR3 FGFR2 LGR6 BCAR1 RUNX1 | 5.29e-05 | 1235 | 61 | 13 | GO:0040007 |
| GeneOntologyBiologicalProcess | cell fate commitment | 6.09e-05 | 338 | 61 | 7 | GO:0045165 | |
| GeneOntologyBiologicalProcess | lung alveolus development | 7.19e-05 | 75 | 61 | 4 | GO:0048286 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | SLC25A46 TBX18 HOXB1 COL12A1 TENM4 FN1 MYOM1 SLC34A1 CECR2 DVL1 TMF1 FGFR2 FGFR4 RUNX1 | 8.46e-05 | 1483 | 61 | 14 | GO:0048646 |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process | 1.03e-04 | 640 | 61 | 9 | GO:0006511 | |
| GeneOntologyBiologicalProcess | modification-dependent protein catabolic process | 1.18e-04 | 651 | 61 | 9 | GO:0019941 | |
| GeneOntologyBiologicalProcess | proteolysis involved in protein catabolic process | 1.24e-04 | 812 | 61 | 10 | GO:0051603 | |
| GeneOntologyBiologicalProcess | modification-dependent macromolecule catabolic process | 1.25e-04 | 656 | 61 | 9 | GO:0043632 | |
| GeneOntologyBiologicalProcess | lung development | 1.42e-04 | 269 | 61 | 6 | GO:0030324 | |
| GeneOntologyBiologicalProcess | tube development | TBX18 DDR1 DLG5 FN1 CECR2 EIF4G1 DVL1 FGFR3 FGFR2 FGFR4 RUNX1 HECA CIC | 1.90e-04 | 1402 | 61 | 13 | GO:0035295 |
| GeneOntologyBiologicalProcess | ear development | 1.94e-04 | 285 | 61 | 6 | GO:0043583 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 2.33e-04 | 713 | 61 | 9 | GO:0048598 | |
| GeneOntologyBiologicalProcess | respiratory system development | 2.79e-04 | 305 | 61 | 6 | GO:0060541 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | 3.06e-04 | 740 | 61 | 9 | GO:1903530 | |
| GeneOntologyBiologicalProcess | developmental growth | 3.13e-04 | 911 | 61 | 10 | GO:0048589 | |
| GeneOntologyBiologicalProcess | protein catabolic process | ZSWIM8 ARRDC1 TPP1 DTL DVL1 TMF1 ZNRF1 PTPN23 STAM SH3RF3 FAF1 | 3.80e-04 | 1115 | 61 | 11 | GO:0030163 |
| GeneOntologyBiologicalProcess | regulation of phosphate transport | 3.81e-04 | 10 | 61 | 2 | GO:0010966 | |
| GeneOntologyBiologicalProcess | gastrulation | 4.08e-04 | 212 | 61 | 5 | GO:0007369 | |
| GeneOntologyBiologicalProcess | regulation of growth | 4.37e-04 | 777 | 61 | 9 | GO:0040008 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 4.56e-04 | 619 | 61 | 8 | GO:0002009 | |
| GeneOntologyBiologicalProcess | canonical Wnt signaling pathway | 5.29e-04 | 344 | 61 | 6 | GO:0060070 | |
| GeneOntologyBiologicalProcess | regulation of secretion | 5.44e-04 | 801 | 61 | 9 | GO:0051046 | |
| GeneOntologyBiologicalProcess | positive regulation of cell proliferation in bone marrow | 5.57e-04 | 12 | 61 | 2 | GO:0071864 | |
| GeneOntologyBiologicalProcess | axon development | 5.80e-04 | 642 | 61 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | lung saccule development | 6.57e-04 | 13 | 61 | 2 | GO:0060430 | |
| GeneOntologyBiologicalProcess | response to sodium phosphate | 6.57e-04 | 13 | 61 | 2 | GO:1904383 | |
| GeneOntologyBiologicalProcess | central nervous system development | SLC25A46 HOXB1 DLG5 TENM4 LHX4 ATN1 TPP1 FGFR3 FGFR2 RUNX1 CIC | 6.89e-04 | 1197 | 61 | 11 | GO:0007417 |
| GeneOntologyBiologicalProcess | cardiac cell fate commitment | 7.65e-04 | 14 | 61 | 2 | GO:0060911 | |
| GeneOntologyBiologicalProcess | response to mercury ion | 7.65e-04 | 14 | 61 | 2 | GO:0046689 | |
| GeneOntologyBiologicalProcess | positive regulation of phospholipase activity | 7.65e-04 | 14 | 61 | 2 | GO:0010518 | |
| GeneOntologyBiologicalProcess | lung epithelium development | 7.84e-04 | 61 | 61 | 3 | GO:0060428 | |
| GeneOntologyBiologicalProcess | protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway | 8.81e-04 | 15 | 61 | 2 | GO:0043328 | |
| GeneOntologyBiologicalProcess | inner ear development | 9.07e-04 | 253 | 61 | 5 | GO:0048839 | |
| GeneOntologyBiologicalProcess | organ growth | 9.56e-04 | 256 | 61 | 5 | GO:0035265 | |
| GeneOntologyBiologicalProcess | peripheral nervous system neuron development | 1.01e-03 | 16 | 61 | 2 | GO:0048935 | |
| GeneOntologyBiologicalProcess | peripheral nervous system neuron differentiation | 1.01e-03 | 16 | 61 | 2 | GO:0048934 | |
| GeneOntologyBiologicalProcess | regulation of cell proliferation in bone marrow | 1.01e-03 | 16 | 61 | 2 | GO:0071863 | |
| GeneOntologyBiologicalProcess | neuron development | SLC25A46 DDR1 DLG5 TENM4 LHX4 FN1 CECR2 DVL1 FGFR3 FGFR2 LGR6 RUNX1 | 1.04e-03 | 1463 | 61 | 12 | GO:0048666 |
| Domain | FGF_rcpt_fam | 1.32e-07 | 4 | 61 | 3 | IPR016248 | |
| Domain | DVL-1 | 1.05e-05 | 2 | 61 | 2 | IPR008340 | |
| Domain | Dishevelled_fam | 6.27e-05 | 4 | 61 | 2 | IPR008339 | |
| Domain | Dishevelled | 6.27e-05 | 4 | 61 | 2 | PF02377 | |
| Domain | Dishevelled_protein_dom | 6.27e-05 | 4 | 61 | 2 | IPR003351 | |
| Domain | NUT | 1.04e-04 | 5 | 61 | 2 | IPR024310 | |
| Domain | NUT_N | 1.04e-04 | 5 | 61 | 2 | IPR024309 | |
| Domain | NUT | 1.04e-04 | 5 | 61 | 2 | PF12881 | |
| Domain | TyrKc | 1.96e-04 | 88 | 61 | 4 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.96e-04 | 88 | 61 | 4 | IPR020635 | |
| Domain | DIX | 2.18e-04 | 7 | 61 | 2 | PF00778 | |
| Domain | DIX | 2.18e-04 | 7 | 61 | 2 | IPR001158 | |
| Domain | DIX | 2.18e-04 | 7 | 61 | 2 | PS50841 | |
| Domain | DAX | 2.18e-04 | 7 | 61 | 2 | SM00021 | |
| Domain | PROTEIN_KINASE_TYR | 2.84e-04 | 97 | 61 | 4 | PS00109 | |
| Domain | Tyr_kinase_AS | 2.84e-04 | 97 | 61 | 4 | IPR008266 | |
| Domain | SH3 | 6.94e-04 | 216 | 61 | 5 | SM00326 | |
| Domain | SH3 | 6.94e-04 | 216 | 61 | 5 | PS50002 | |
| Domain | SH3_domain | 7.54e-04 | 220 | 61 | 5 | IPR001452 | |
| Domain | Pkinase_Tyr | 8.36e-04 | 129 | 61 | 4 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 1.07e-03 | 138 | 61 | 4 | IPR001245 | |
| Domain | SH3_1 | 2.03e-03 | 164 | 61 | 4 | PF00018 | |
| Domain | DEP | 2.32e-03 | 22 | 61 | 2 | PF00610 | |
| Domain | DEP | 2.32e-03 | 22 | 61 | 2 | PS50186 | |
| Domain | DEP | 2.32e-03 | 22 | 61 | 2 | SM00049 | |
| Domain | DEP_dom | 2.54e-03 | 23 | 61 | 2 | IPR000591 | |
| Domain | Ig_I-set | 3.45e-03 | 190 | 61 | 4 | IPR013098 | |
| Domain | I-set | 3.45e-03 | 190 | 61 | 4 | PF07679 | |
| Domain | - | 5.70e-03 | 663 | 61 | 7 | 2.60.40.10 | |
| Domain | IGc2 | 7.28e-03 | 235 | 61 | 4 | SM00408 | |
| Domain | Ig_sub2 | 7.28e-03 | 235 | 61 | 4 | IPR003598 | |
| Domain | Ig-like_fold | 7.95e-03 | 706 | 61 | 7 | IPR013783 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.11e-05 | 150 | 48 | 6 | M39520 | |
| Pathway | WP_REGULATION_OF_ACTIN_CYTOSKELETON | 1.20e-05 | 152 | 48 | 6 | MM15834 | |
| Pathway | WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS | 6.25e-05 | 23 | 48 | 3 | M39862 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 8.02e-05 | 213 | 48 | 6 | M18306 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 8.08e-05 | 25 | 48 | 3 | M47934 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY | 1.56e-04 | 31 | 48 | 3 | M47396 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY | 2.25e-04 | 35 | 48 | 3 | M47379 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 3.25e-04 | 97 | 48 | 4 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 3.79e-04 | 101 | 48 | 4 | M39448 | |
| Pathway | REACTOME_IRS_MEDIATED_SIGNALLING | 5.75e-04 | 48 | 48 | 3 | M26916 | |
| Pathway | WP_BURN_WOUND_HEALING | 5.80e-04 | 113 | 48 | 4 | M42571 | |
| Pathway | WP_VEGFAVEGFR2_SIGNALING | 5.92e-04 | 431 | 48 | 7 | M39729 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 6.39e-04 | 313 | 48 | 6 | M27867 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 6.41e-04 | 116 | 48 | 4 | MM15863 | |
| Pathway | WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY | 6.49e-04 | 50 | 48 | 3 | M48087 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 6.61e-04 | 439 | 48 | 7 | M42563 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 6.62e-04 | 117 | 48 | 4 | M39530 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | 6.83e-04 | 118 | 48 | 4 | M713 | |
| Pathway | REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R | 8.14e-04 | 54 | 48 | 3 | M27168 | |
| Pathway | REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE | 8.14e-04 | 54 | 48 | 3 | M620 | |
| Pathway | PID_FGF_PATHWAY | 8.58e-04 | 55 | 48 | 3 | M276 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY | 8.58e-04 | 55 | 48 | 3 | M47952 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.16e-03 | 15 | 48 | 2 | M12101 | |
| Pathway | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | 1.16e-03 | 15 | 48 | 2 | MM14961 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 1.27e-03 | 63 | 48 | 3 | M635 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.52e-03 | 67 | 48 | 3 | MM15345 | |
| Pathway | WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY | 1.68e-03 | 18 | 48 | 2 | M39586 | |
| Pathway | WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS | 1.68e-03 | 18 | 48 | 2 | M39421 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.78e-03 | 258 | 48 | 5 | MM14572 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.01e-03 | 532 | 48 | 7 | M27870 | |
| Pathway | WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA | 2.03e-03 | 74 | 48 | 3 | M39857 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.03e-03 | 74 | 48 | 3 | M160 | |
| Pubmed | 1.40e-08 | 15 | 64 | 4 | 28465335 | ||
| Pubmed | 1.87e-08 | 16 | 64 | 4 | 24470103 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 9664689 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 9212826 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 27154171 | ||
| Pubmed | Amplification of FRS2 and activation of FGFR/FRS2 signaling pathway in high-grade liposarcoma. | 2.37e-08 | 4 | 64 | 3 | 23393200 | |
| Pubmed | Immunolocalization of fibroblast growth factor receptors in normal and wounded human skin. | 2.37e-08 | 4 | 64 | 3 | 12373339 | |
| Pubmed | FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer. | 2.37e-08 | 4 | 64 | 3 | 36142417 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 11759058 | ||
| Pubmed | The FGF system has a key role in regulating vascular integrity. | 2.37e-08 | 4 | 64 | 3 | 18776942 | |
| Pubmed | RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector. | 2.37e-08 | 4 | 64 | 3 | 17304337 | |
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 16210019 | ||
| Pubmed | 2.37e-08 | 4 | 64 | 3 | 12644244 | ||
| Pubmed | 3.96e-08 | 19 | 64 | 4 | 16049112 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 27206683 | ||
| Pubmed | Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference. | 5.93e-08 | 5 | 64 | 3 | 15987787 | |
| Pubmed | The expression profiles of fibroblast growth factor 9 and its receptors in developing mice testes. | 5.93e-08 | 5 | 64 | 3 | 27078042 | |
| Pubmed | Different intracellular trafficking of FGF1 endocytosed by the four homologous FGF receptors. | 5.93e-08 | 5 | 64 | 3 | 16091423 | |
| Pubmed | FGF-dependent regulation of VEGF receptor 2 expression in mice. | 5.93e-08 | 5 | 64 | 3 | 21633168 | |
| Pubmed | Expression of fibroblast growth factor receptors in peri-implantation mouse embryos. | 5.93e-08 | 5 | 64 | 3 | 9771645 | |
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 28094278 | ||
| Pubmed | 5.93e-08 | 5 | 64 | 3 | 9013630 | ||
| Pubmed | The mouse Fgfrl1 gene coding for a novel FGF receptor-like protein. | 5.93e-08 | 5 | 64 | 3 | 11566361 | |
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 10572038 | ||
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 9010207 | ||
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 16365308 | ||
| Pubmed | Regulation of fibroblast growth factor-23 signaling by klotho. | 1.18e-07 | 6 | 64 | 3 | 16436388 | |
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 19232523 | ||
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 29720668 | ||
| Pubmed | 1.18e-07 | 6 | 64 | 3 | 19515808 | ||
| Pubmed | Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1. | 1.18e-07 | 6 | 64 | 3 | 24026051 | |
| Pubmed | FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development. | 1.28e-07 | 25 | 64 | 4 | 18625063 | |
| Pubmed | 2.07e-07 | 7 | 64 | 3 | 16772167 | ||
| Pubmed | 2.07e-07 | 7 | 64 | 3 | 8959336 | ||
| Pubmed | Expression patterns of FGF receptors in the developing mammalian cochlea. | 2.07e-07 | 7 | 64 | 3 | 20131355 | |
| Pubmed | Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. | 2.39e-07 | 29 | 64 | 4 | 14522949 | |
| Pubmed | 3.31e-07 | 8 | 64 | 3 | 18187602 | ||
| Pubmed | 3.31e-07 | 8 | 64 | 3 | 17623664 | ||
| Pubmed | Syndecan-4 dependent FGF stimulation of mouse vibrissae growth. | 3.31e-07 | 8 | 64 | 3 | 16989989 | |
| Pubmed | Expression of Fgf receptors 1, 2, and 3 in the developing mid- and hindbrain of the mouse. | 4.95e-07 | 9 | 64 | 3 | 15830353 | |
| Pubmed | Dynamic activation of Wnt, Fgf, and Hh signaling during soft palate development. | 4.95e-07 | 9 | 64 | 3 | 31613912 | |
| Pubmed | Integration of FGF and TWIST in calvarial bone and suture development. | 4.95e-07 | 9 | 64 | 3 | 10751173 | |
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 26456826 | ||
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 11335076 | ||
| Pubmed | 4.95e-07 | 9 | 64 | 3 | 15229180 | ||
| Pubmed | 7.07e-07 | 10 | 64 | 3 | 15470137 | ||
| Pubmed | Regulation of external genitalia development by concerted actions of FGF ligands and FGF receptors. | 7.07e-07 | 10 | 64 | 3 | 15340846 | |
| Pubmed | 9.06e-07 | 40 | 64 | 4 | 30898150 | ||
| Pubmed | 9.70e-07 | 11 | 64 | 3 | 8901049 | ||
| Pubmed | Fgf20 is required for sensory epithelial specification in the developing cochlea. | 9.70e-07 | 11 | 64 | 3 | 18524904 | |
| Pubmed | 9.70e-07 | 11 | 64 | 3 | 26906157 | ||
| Pubmed | The murine gene, Traube, is essential for the growth of preimplantation embryos. | 9.70e-07 | 11 | 64 | 3 | 11071758 | |
| Pubmed | A local source of FGF initiates development of the unmyelinated lineage of sensory neurons. | 1.11e-06 | 42 | 64 | 4 | 24198358 | |
| Pubmed | 1.13e-06 | 99 | 64 | 5 | 31723608 | ||
| Pubmed | Immunohistochemical study of genesis of the mouse oral vestibule. | 1.29e-06 | 12 | 64 | 3 | 14964469 | |
| Pubmed | 1.29e-06 | 12 | 64 | 3 | 10751172 | ||
| Pubmed | 1.29e-06 | 12 | 64 | 3 | 12460940 | ||
| Pubmed | The roles of FGF signaling in germ cell migration in the mouse. | 1.29e-06 | 12 | 64 | 3 | 16291796 | |
| Pubmed | 1.29e-06 | 12 | 64 | 3 | 7959747 | ||
| Pubmed | 1.68e-06 | 13 | 64 | 3 | 9385055 | ||
| Pubmed | A point mutation in Fgf9 impedes joint interzone formation leading to multiple synostoses syndrome. | 1.68e-06 | 13 | 64 | 3 | 28169396 | |
| Pubmed | Testis Determination Requires a Specific FGFR2 Isoform to Repress FOXL2. | 1.68e-06 | 13 | 64 | 3 | 28938467 | |
| Pubmed | 1.68e-06 | 13 | 64 | 3 | 8883961 | ||
| Pubmed | Receptor specificity of the fibroblast growth factor family. | 1.68e-06 | 13 | 64 | 3 | 8663044 | |
| Pubmed | FGF8 is essential for formation of the ductal system in the male reproductive tract. | 2.66e-06 | 15 | 64 | 3 | 22110055 | |
| Pubmed | 3.27e-06 | 16 | 64 | 3 | 15201220 | ||
| Pubmed | 3.27e-06 | 16 | 64 | 3 | 11731698 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 22178476 | ||
| Pubmed | Fibroblast growth factor receptor 3 is a negative regulator of bone growth. | 3.33e-06 | 2 | 64 | 2 | 8601314 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 38328983 | ||
| Pubmed | Genetic variants in FGFR2 and FGFR4 genes and skin cancer risk in the Nurses' Health Study. | 3.33e-06 | 2 | 64 | 2 | 19500394 | |
| Pubmed | Activation of FGF receptors by mutations in the transmembrane domain. | 3.33e-06 | 2 | 64 | 2 | 9136983 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 33853673 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 35303508 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 32822871 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 21152424 | ||
| Pubmed | FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. | 3.33e-06 | 2 | 64 | 2 | 9716527 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 20093646 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 26431494 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 17957151 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 11325814 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 23325524 | ||
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 8644734 | ||
| Pubmed | Inhibitor-sensitive FGFR2 and FGFR3 mutations in lung squamous cell carcinoma. | 3.33e-06 | 2 | 64 | 2 | 23786770 | |
| Pubmed | 3.33e-06 | 2 | 64 | 2 | 26170285 | ||
| Pubmed | FGF8 Signaling Alters the Osteogenic Cell Fate in the Hard Palate. | 3.97e-06 | 17 | 64 | 3 | 29342370 | |
| Pubmed | Fgf21 regulates T-cell development in the neonatal and juvenile thymus. | 4.75e-06 | 18 | 64 | 3 | 28336912 | |
| Pubmed | Feto-maternal cholesterol transport regulated by β-Klotho-FGF15 axis is essential for fetal growth. | 5.64e-06 | 19 | 64 | 3 | 37541847 | |
| Pubmed | TGF-β signaling and Creb5 cooperatively regulate Fgf18 to control pharyngeal muscle development. | 6.63e-06 | 20 | 64 | 3 | 36542062 | |
| Pubmed | 7.72e-06 | 21 | 64 | 3 | 10579907 | ||
| Pubmed | MT1-MMP inactivates ADAM9 to regulate FGFR2 signaling and calvarial osteogenesis. | 7.72e-06 | 21 | 64 | 3 | 22632802 | |
| Pubmed | Expression of members of the Fgf family and their receptors during midfacial development. | 8.93e-06 | 22 | 64 | 3 | 11165488 | |
| Pubmed | 8.93e-06 | 22 | 64 | 3 | 12514106 | ||
| Pubmed | FGF9 suppresses meiosis and promotes male germ cell fate in mice. | 8.93e-06 | 22 | 64 | 3 | 20833365 | |
| Pubmed | Epicardial function of canonical Wnt-, Hedgehog-, Fgfr1/2-, and Pdgfra-signalling. | 8.93e-06 | 22 | 64 | 3 | 24000064 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 31189094 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 31201269 | ||
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 28056982 | ||
| Pubmed | The cell surface receptor FGFRL1 forms constitutive dimers that promote cell adhesion. | 9.99e-06 | 3 | 64 | 2 | 18061161 | |
| Pubmed | 9.99e-06 | 3 | 64 | 2 | 18829569 | ||
| Interaction | SEC24B interactions | 7.93e-07 | 240 | 63 | 8 | int:SEC24B | |
| Interaction | FGF6 interactions | 1.01e-06 | 7 | 63 | 3 | int:FGF6 | |
| Interaction | FGF18 interactions | 1.01e-06 | 7 | 63 | 3 | int:FGF18 | |
| Interaction | FGF5 interactions | 1.61e-06 | 8 | 63 | 3 | int:FGF5 | |
| Interaction | FGF23 interactions | 1.61e-06 | 8 | 63 | 3 | int:FGF23 | |
| Interaction | HGS interactions | 4.73e-06 | 523 | 63 | 10 | int:HGS | |
| Interaction | KLB interactions | 6.28e-06 | 12 | 63 | 3 | int:KLB | |
| Interaction | KL interactions | 1.03e-05 | 14 | 63 | 3 | int:KL | |
| Interaction | YWHAB interactions | DLG5 FN1 SEC24A DTL EIF4G1 FGFR3 FGFR2 FGFR4 STAM BCAR1 PIP4K2C SH3RF3 CIC | 1.23e-05 | 1014 | 63 | 13 | int:YWHAB |
| Interaction | FGF7 interactions | 1.58e-05 | 16 | 63 | 3 | int:FGF7 | |
| Interaction | FGF9 interactions | 1.58e-05 | 16 | 63 | 3 | int:FGF9 | |
| Interaction | CRLF2 interactions | 3.96e-05 | 61 | 63 | 4 | int:CRLF2 | |
| Interaction | HSPA1B interactions | 4.18e-05 | 301 | 63 | 7 | int:HSPA1B | |
| Interaction | GOPC interactions | 4.36e-05 | 303 | 63 | 7 | int:GOPC | |
| Interaction | SEC24A interactions | 7.06e-05 | 224 | 63 | 6 | int:SEC24A | |
| Interaction | ZNF326 interactions | 7.06e-05 | 224 | 63 | 6 | int:ZNF326 | |
| Interaction | CDK1 interactions | 8.59e-05 | 590 | 63 | 9 | int:CDK1 | |
| Interaction | STAM2 interactions | 9.65e-05 | 147 | 63 | 5 | int:STAM2 | |
| Interaction | CBFA2T3 interactions | 1.04e-04 | 78 | 63 | 4 | int:CBFA2T3 | |
| Interaction | STAM interactions | 1.16e-04 | 153 | 63 | 5 | int:STAM | |
| Interaction | WDR5 interactions | ATN1 FN1 UBAP2L TPP1 DTL EIF4G1 PPP1R3F CHD3 ALDH1B1 RUNX1 CIC HNRNPR | 1.34e-04 | 1101 | 63 | 12 | int:WDR5 |
| Interaction | LILRA5 interactions | 1.35e-04 | 32 | 63 | 3 | int:LILRA5 | |
| Interaction | FGFR1 interactions | 1.45e-04 | 632 | 63 | 9 | int:FGFR1 | |
| Interaction | NCK2 interactions | 1.67e-04 | 262 | 63 | 6 | int:NCK2 | |
| Interaction | XRN2 interactions | 1.82e-04 | 381 | 63 | 7 | int:XRN2 | |
| Interaction | CLTC interactions | 1.89e-04 | 655 | 63 | 9 | int:CLTC | |
| Interaction | UROD interactions | 2.10e-04 | 37 | 63 | 3 | int:UROD | |
| Interaction | C1QB interactions | 2.14e-04 | 94 | 63 | 4 | int:C1QB | |
| Interaction | WDR26 interactions | 2.42e-04 | 179 | 63 | 5 | int:WDR26 | |
| Interaction | WWP2 interactions | ATN1 DAZAP1 UBAP2L ARRDC1 EIF4G1 DVL1 PPP1R13B STAM FAF1 HNRNPR | 2.58e-04 | 840 | 63 | 10 | int:WWP2 |
| Interaction | UNK interactions | 2.76e-04 | 408 | 63 | 7 | int:UNK | |
| Interaction | FBXO2 interactions | 2.88e-04 | 411 | 63 | 7 | int:FBXO2 | |
| Interaction | FRS2 interactions | 2.93e-04 | 102 | 63 | 4 | int:FRS2 | |
| Interaction | SMAP2 interactions | 3.11e-04 | 189 | 63 | 5 | int:SMAP2 | |
| Interaction | BCAR1 interactions | 3.25e-04 | 556 | 63 | 8 | int:BCAR1 | |
| Interaction | ZMYND8 interactions | 3.27e-04 | 191 | 63 | 5 | int:ZMYND8 | |
| Interaction | ZFYVE9 interactions | 3.39e-04 | 106 | 63 | 4 | int:ZFYVE9 | |
| Interaction | FGF4 interactions | 3.52e-04 | 44 | 63 | 3 | int:FGF4 | |
| Interaction | FGF1 interactions | 3.52e-04 | 44 | 63 | 3 | int:FGF1 | |
| Interaction | FGF17 interactions | 3.52e-04 | 44 | 63 | 3 | int:FGF17 | |
| Interaction | DDX17 interactions | 3.58e-04 | 426 | 63 | 7 | int:DDX17 | |
| Interaction | TSG101 interactions | 3.64e-04 | 303 | 63 | 6 | int:TSG101 | |
| Interaction | FXR2 interactions | 3.79e-04 | 430 | 63 | 7 | int:FXR2 | |
| Interaction | FUBP1 interactions | 4.04e-04 | 309 | 63 | 6 | int:FUBP1 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.29e-06 | 40 | 37 | 4 | 321 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.18e-04 | 161 | 37 | 4 | 593 | |
| GeneFamily | Fibronectin type III domain containing | 4.24e-03 | 160 | 37 | 3 | 555 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.32e-03 | 394 | 37 | 4 | 471 | |
| GeneFamily | RNA binding motif containing | 9.33e-03 | 213 | 37 | 3 | 725 | |
| Coexpression | VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP | 6.90e-06 | 16 | 62 | 3 | M14495 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP | 1.88e-05 | 22 | 62 | 3 | M205 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | EBF2 TBX18 NPTX2 COL12A1 TENM4 FN1 EIF4EBP1 DTL FGFR3 FGFR2 RUNX1 | 3.88e-05 | 1074 | 62 | 11 | M1941 |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP | 8.79e-05 | 190 | 62 | 5 | M9871 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_24HR | 9.25e-05 | 37 | 62 | 3 | MM1170 | |
| Coexpression | HU_GENOTOXIC_DAMAGE_24HR | 9.25e-05 | 37 | 62 | 3 | M1531 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN | 1.09e-04 | 199 | 62 | 5 | M6632 | |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN | 1.09e-04 | 199 | 62 | 5 | M8587 | |
| Coexpression | GSE27786_LIN_NEG_VS_NEUTROPHIL_DN | 1.12e-04 | 200 | 62 | 5 | M4795 | |
| Coexpression | RICKMAN_HEAD_AND_NECK_CANCER_A | 1.13e-04 | 105 | 62 | 4 | M14228 | |
| ToppCell | PND01-03-samps-Mesenchymal|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.25e-08 | 194 | 64 | 7 | 4f9bd0ded0dde1df885850714f29e73e992539a5 | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.35e-08 | 196 | 64 | 7 | 54f4cf778f95a9ff662e5c7520916a25e605bf95 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 1.91e-07 | 174 | 64 | 6 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.98e-07 | 175 | 64 | 6 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.49e-07 | 182 | 64 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.49e-07 | 182 | 64 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.74e-07 | 185 | 64 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.92e-07 | 187 | 64 | 6 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.11e-07 | 189 | 64 | 6 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.31e-07 | 191 | 64 | 6 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.62e-07 | 194 | 64 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.73e-07 | 195 | 64 | 6 | ec12cfb2fce44cc2de4e198ef5af075e626f0329 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.08e-07 | 198 | 64 | 6 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.88e-06 | 164 | 64 | 5 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-06 | 169 | 64 | 5 | 1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 4.49e-06 | 169 | 64 | 5 | 58098f8801ca941aeddafb47e88ab0df8b9edb57 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.62e-06 | 170 | 64 | 5 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.44e-06 | 182 | 64 | 5 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.16e-06 | 186 | 64 | 5 | 4d68ee3d32f7ef884faf402ef92b31b0eb4656f1 | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 7.54e-06 | 188 | 64 | 5 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.54e-06 | 188 | 64 | 5 | 9b95730ddd13eb4624321bab3ab4989414977ca3 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 7.74e-06 | 189 | 64 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.94e-06 | 190 | 64 | 5 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.94e-06 | 190 | 64 | 5 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.94e-06 | 190 | 64 | 5 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.35e-06 | 192 | 64 | 5 | 2802fae55683345ff94a1ecf73b6fbee4f17481e | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.35e-06 | 192 | 64 | 5 | e79f2253e084a9ab9afcaf7ec42a5012ade42d36 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.56e-06 | 193 | 64 | 5 | 8d05805295c5d3aa93aeb38be5fbefa81e1be1f0 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.56e-06 | 193 | 64 | 5 | 1b2cc627b2aa002b442358bd1188d470e67ce7d9 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 8.56e-06 | 193 | 64 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-06 | 194 | 64 | 5 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.78e-06 | 194 | 64 | 5 | 85e00861c5068a27d0cf0ae677f420c8245baa9a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 195 | 64 | 5 | b616ee6f1d878935d293c8e0a8bbc5b4385301f0 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 195 | 64 | 5 | 6bb6349d6ec8da094fe1c7c590021989337aeb0b | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 9.00e-06 | 195 | 64 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 195 | 64 | 5 | a3b468125e48f072255cede7645f6692298ecf54 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 195 | 64 | 5 | 2f9a274b26fc528a85f50933ec2f4db1dc9da0ca | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 9.23e-06 | 196 | 64 | 5 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.23e-06 | 196 | 64 | 5 | 3dc6394c5de1f875a19ad0e8799827fad29f8f02 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.23e-06 | 196 | 64 | 5 | 617103f4a09e009fe96c28eb5e40505a4fd6dcf4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.23e-06 | 196 | 64 | 5 | db64ab27374f82553ee577aec056141170f3656f | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.23e-06 | 196 | 64 | 5 | 754a3613340932563cd8424d775e18b93c3a1aaa | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.23e-06 | 196 | 64 | 5 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 9.23e-06 | 196 | 64 | 5 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.46e-06 | 197 | 64 | 5 | 06a0d7062dadda656decaf77dcef9a10b5f2698d | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.46e-06 | 197 | 64 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.46e-06 | 197 | 64 | 5 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.46e-06 | 197 | 64 | 5 | d35c7a36135b5ed6a7bf2f934849678eba2a0177 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.69e-06 | 198 | 64 | 5 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-06 | 198 | 64 | 5 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.69e-06 | 198 | 64 | 5 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 9.69e-06 | 198 | 64 | 5 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.69e-06 | 198 | 64 | 5 | bc9c9f2c87282b5ef8514773e065d2a6b5dde338 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.93e-06 | 199 | 64 | 5 | 95d95e9b7bd3933188998ae94986213eb0f1e5ea | |
| ToppCell | TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma-Intrahepatic|TCGA-Bile_Duct / Sample_Type by Project: Shred V9 | 1.02e-05 | 200 | 64 | 5 | 1fa8422fd820d21e285a7e7c4c6fbd8b7277d2af | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-05 | 145 | 64 | 4 | 186b8bd8ac2d5c66cc29fdc2dd6751eddce3e8b8 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.29e-05 | 149 | 64 | 4 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | COVID-19-Heart-Adipocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.97e-05 | 153 | 64 | 4 | 93958bd9c951222ba5b740d1cb83fd5d78a10e1e | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.51e-05 | 156 | 64 | 4 | 029ba0832ee9c4a2c85620e4df2260e02d86b45c | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Junb_(Mural,_IEG+)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 7.51e-05 | 156 | 64 | 4 | 5df19a235843829f5a1a90ca21b0964ef8b4e115 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-05 | 159 | 64 | 4 | cfb4a8c8aac34b1a857956d98382d487abcf5444 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 8.09e-05 | 159 | 64 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-05 | 159 | 64 | 4 | 7cda111bb98f1241989e49d490bdf51a712ea589 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.09e-05 | 159 | 64 | 4 | a75ab494959575143cefdaec99e7aee3f318d559 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.56e-05 | 166 | 64 | 4 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.78e-05 | 167 | 64 | 4 | c4e321bb87512ea839f324c92c0f1afea891483f | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 171 | 64 | 4 | 5447b78148f7bccb727e2fc108589b2af02a5d31 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 172 | 64 | 4 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.10e-04 | 172 | 64 | 4 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 172 | 64 | 4 | a7eee0a30d2fe20c865a07b9004c6a821a72c0c4 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 172 | 64 | 4 | 0a9fe2cd28203970295a1288078c66eadac1c9ed | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.12e-04 | 173 | 64 | 4 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.17e-04 | 175 | 64 | 4 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.22e-04 | 177 | 64 | 4 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.28e-04 | 179 | 64 | 4 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 180 | 64 | 4 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 180 | 64 | 4 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | Bronchial_Biopsy-Mesenchymal-Smooth_muscle|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.31e-04 | 180 | 64 | 4 | 7085a851807e6a833965e1366946db0bbc5174e2 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.31e-04 | 180 | 64 | 4 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 1.31e-04 | 180 | 64 | 4 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.33e-04 | 181 | 64 | 4 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-04 | 182 | 64 | 4 | 19c5e3a9d9b3728303b682102e276adfe93aa759 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-04 | 182 | 64 | 4 | 97bb07478f56a937b490fba121ee603db64134a1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-04 | 182 | 64 | 4 | 1c1a687f728341c209b048b6715bcddd0ac20069 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.36e-04 | 182 | 64 | 4 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.36e-04 | 182 | 64 | 4 | ad4d74d8b19976e1ccc3c5ba8013199338cf6fd8 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.39e-04 | 183 | 64 | 4 | a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 1.39e-04 | 183 | 64 | 4 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 183 | 64 | 4 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 184 | 64 | 4 | a6dee97ee4ef9d89e11d17339e0dadaea1210ce5 | |
| ToppCell | Cerebellum-Macroglia|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.42e-04 | 184 | 64 | 4 | 91b047a01d2cad231308279ca37fa699630f7864 | |
| ToppCell | COPD-Stromal-Pericyte|COPD / Disease state, Lineage and Cell class | 1.42e-04 | 184 | 64 | 4 | a56264a22dfc2d3672b20134ab7c3c7c23da5ae1 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.42e-04 | 184 | 64 | 4 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 1.42e-04 | 184 | 64 | 4 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 184 | 64 | 4 | 54e5b63f55b8d6eccad53d389ea9c78f991e1414 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 184 | 64 | 4 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.42e-04 | 184 | 64 | 4 | 7b5678718719020b52e7c2a7bd9797987defd7ff | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-04 | 185 | 64 | 4 | b5277190866d9eb5b85eceaa5ba116ea6e6f286b | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.45e-04 | 185 | 64 | 4 | 46460e74cc613df9043f5404e7342aa13cc34873 | |
| ToppCell | (00)_Basal-(4)_1wkpi|(00)_Basal / shred by cell type and Timepoint | 1.45e-04 | 185 | 64 | 4 | bf82ba905e5eee1c39a2731702071d3de10a78b8 | |
| Drug | chlorate | 1.42e-08 | 103 | 63 | 7 | CID000019654 | |
| Drug | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 8.06e-08 | 4 | 63 | 3 | ctd:C568950 | |
| Drug | Palifermin | 4.01e-07 | 6 | 63 | 3 | DB00039 | |
| Drug | 7-methylguanosine triphosphate | 7.54e-06 | 2 | 63 | 2 | ctd:C017516 | |
| Drug | wortmannin; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.39e-05 | 189 | 63 | 6 | 869_DN | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.65e-05 | 195 | 63 | 6 | 4318_UP | |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; PC3; HT_HG-U133A | 1.70e-05 | 196 | 63 | 6 | 4206_DN | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; HL60; HT_HG-U133A | 1.70e-05 | 196 | 63 | 6 | 2361_DN | |
| Drug | Homosalate [118-56-9]; Up 200; 15.2uM; PC3; HT_HG-U133A | 1.80e-05 | 198 | 63 | 6 | 3797_UP | |
| Disease | bone disease (implicated_via_orthology) | 8.38e-08 | 5 | 61 | 3 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 3.80e-06 | 447 | 61 | 8 | C3714756 | |
| Disease | Isolated coronal synostosis | 4.20e-06 | 2 | 61 | 2 | cv:CN043619 | |
| Disease | Lacrimoauriculodentodigital syndrome | 1.26e-05 | 3 | 61 | 2 | C0265269 | |
| Disease | Saethre-Chotzen Syndrome | 1.26e-05 | 3 | 61 | 2 | C0175699 | |
| Disease | Congenital hypoplasia of radius | 1.26e-05 | 3 | 61 | 2 | C0685381 | |
| Disease | Levy-Hollister syndrome | 1.26e-05 | 3 | 61 | 2 | cv:C0265269 | |
| Disease | TWIST1-related craniosynostosis | 2.52e-05 | 4 | 61 | 2 | cv:C4551902 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 4.19e-05 | 5 | 61 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | Craniosynostosis syndrome | 8.77e-05 | 7 | 61 | 2 | cv:C0010278 | |
| Disease | high grade glioma (implicated_via_orthology) | 1.05e-04 | 44 | 61 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 1.73e-04 | 52 | 61 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | craniosynostosis (is_implicated_in) | 2.74e-04 | 12 | 61 | 2 | DOID:2340 (is_implicated_in) | |
| Disease | Prostatic Neoplasms | 2.74e-04 | 616 | 61 | 7 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.74e-04 | 616 | 61 | 7 | C0376358 | |
| Disease | femoral neck bone geometry | 3.76e-04 | 14 | 61 | 2 | EFO_0004511 | |
| Disease | Nonorganic psychosis | 4.00e-04 | 69 | 61 | 3 | C0349204 | |
| Disease | Limb Deformities, Congenital | 5.60e-04 | 17 | 61 | 2 | C0206762 | |
| Disease | Brachycephaly | 5.60e-04 | 17 | 61 | 2 | C0221356 | |
| Disease | Cleft Palate | 6.39e-04 | 81 | 61 | 3 | C0008925 | |
| Disease | Giant Cell Glioblastoma | 7.11e-04 | 84 | 61 | 3 | C0334588 | |
| Disease | idiopathic pulmonary fibrosis (is_marker_for) | 1.03e-03 | 23 | 61 | 2 | DOID:0050156 (is_marker_for) | |
| Disease | Psychotic Disorders | 1.21e-03 | 101 | 61 | 3 | C0033975 | |
| Disease | oral squamous cell carcinoma (is_implicated_in) | 1.53e-03 | 28 | 61 | 2 | DOID:0050866 (is_implicated_in) | |
| Disease | large artery stroke | 1.67e-03 | 113 | 61 | 3 | EFO_0005524 | |
| Disease | Squamous cell carcinoma of lung | 2.00e-03 | 32 | 61 | 2 | C0149782 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DGGVVDSGVYAVPPP | 401 | P56945 | |
| PPGVVNIITGYGPTA | 231 | P30837 | |
| TGGNTYAVPALPPGA | 581 | Q08345 | |
| EIFTLGGSPYPGIPV | 681 | P22455 | |
| GGSPYPGIPVEELFS | 686 | P22455 | |
| GSAVATVPPYLGPDT | 866 | P54259 | |
| GVQLPPGDYSTTPGG | 26 | Q13541 | |
| PGFLNGSPTGSPYGI | 496 | Q9HAK2 | |
| TSYGETGVPVPPFGC | 41 | Q9NZJ0 | |
| PFTSYIVSTPPGGFP | 261 | Q96EP5 | |
| PGLTGGTVSQFPPLY | 1126 | Q9BXF3 | |
| VGPYIQVPSAGSFPV | 346 | Q96KQ4 | |
| TVPYFAEGSGGPVPT | 381 | Q8N5I2 | |
| PSVGGQIIPPAGYFS | 216 | Q8IUZ5 | |
| GQPYGPTFTTGDVIG | 156 | Q6VN20 | |
| HGVVSSPYVGVGPAP | 841 | Q9H3S7 | |
| IFTLGGSPYPGIPVE | 696 | P21802 | |
| GGSPGQSPPTGYSIL | 266 | Q9UBI9 | |
| GRPPGLETYGFPSVT | 886 | Q9HBX8 | |
| TAPVTSYVEPGSGPF | 86 | Q9Y5Z4 | |
| GLPGGSSYPPASVSQ | 86 | F2Z398 | |
| FEPISSDEGPGTYPG | 1401 | Q2LD37 | |
| PPDSVYSGVQPGIGT | 151 | O43390 | |
| VVGPPQPAEGAGSTY | 91 | Q8TDM6 | |
| GSSVGYPDFPTSPGS | 366 | Q969G2 | |
| SGFIGSEGFPGVYPP | 41 | Q9UKZ9 | |
| TYVTPPGTGFLPGDT | 31 | Q9NPF4 | |
| IPGTSAYAFPSLGPV | 41 | Q06495 | |
| TLGVPFPSSAPSGYA | 71 | P14653 | |
| SFSAPYPTAGGSAGP | 186 | Q96B18 | |
| GYPSTVSTVEGHGPP | 1831 | Q13936 | |
| SVIPEYFSGPGTPLT | 791 | Q99715 | |
| GPRGVPAGTAVTPNY | 191 | Q9GZZ7 | |
| TGYRVTTTPKNGPGP | 1661 | P02751 | |
| ATPPGYGAAFSAAPV | 1926 | Q12873 | |
| PSIFVGPTGTGKSVY | 1971 | Q8WXX0 | |
| APGFYPGASPTEFGT | 126 | Q04637 | |
| PTTKAYTVVGGPPGG | 646 | O14640 | |
| YGGETIPGPAFNPAS | 56 | Q9UNN5 | |
| EIFTLGGSPYPGIPV | 686 | P22607 | |
| PTTKAYTVVGGPPGG | 621 | P54792 | |
| PVGAYFPGGSVTPVS | 196 | O15382 | |
| GLTPVFGPYTRPSES | 216 | Q5EB52 | |
| PTVPLVSGTPGAYAV | 941 | Q5VV67 | |
| TGPPALVGSYGTSPE | 316 | Q8TBX8 | |
| AYPALGPGVTANPGT | 56 | Q5VT03 | |
| AYPVLGPGVTVNPGT | 6 | A1L443 | |
| AYPVLGPGVTVNPGT | 6 | Q5VZR2 | |
| FTYSPTPVTSGIGIG | 326 | Q01196 | |
| GATGVPPSSLNYPSG | 306 | O95486 | |
| SPGIGTPFSYAVPGQ | 261 | P47972 | |
| APGGPVITAFYSGSP | 1086 | Q96RK0 | |
| TIPYGEPGISSPVSG | 41 | P82094 | |
| GVPGLPSTFQYGPAV | 916 | Q14157 | |
| TPYEGPTEEPFSSGG | 71 | Q96AG3 | |
| GETFAPPRTPSYVGV | 446 | O95935 | |
| PGNYVTPVSRVPAGG | 516 | Q8TEJ3 | |
| PVPTDVSLYPSGGTG | 391 | Q6N022 | |
| SSGVSGSQVYAGPPP | 396 | Q92783 | |
| PVPAGGGFYLVPTFS | 106 | Q6ZSY5 | |
| GGVYFSEGPEPPTAS | 671 | A7E2V4 | |
| VTGREGFPTDAPYPT | 121 | P17098 | |
| GPPGGAVSATAYPDT | 6 | Q69YG0 | |
| PSTAGGVPFGLYTPA | 61 | Q8ND25 | |
| PTFPASSPYVTTVGG | 376 | O14773 | |
| PPVHSGRTPVTGYFV | 1061 | P52179 |